Defective DNA Repair and Neurodegenerative Disease

[1]  N. Mailand,et al.  Human Xip1 (C2orf13) Is a Novel Regulator of Cellular Responses to DNA Strand Breaks* , 2007, Journal of Biological Chemistry.

[2]  M. Gatei,et al.  Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage , 2007, The Journal of cell biology.

[3]  P. Mckinnon,et al.  BRCA2 is required for neurogenesis and suppression of medulloblastoma , 2007, The EMBO journal.

[4]  S. Tsuji,et al.  Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3′-phosphate and 3′-phosphoglycolate ends , 2007, Nucleic acids research.

[5]  S. Nakajima,et al.  A novel human AP endonuclease with conserved zinc‐finger‐like motifs involved in DNA strand break responses , 2007, The EMBO journal.

[6]  N. Gueven,et al.  A subgroup of spinocerebellar ataxias defective in DNA damage responses , 2007, Neuroscience.

[7]  E. Dogliotti,et al.  Base damage and single-strand break repair: mechanisms and functional significance of short- and long-patch repair subpathways. , 2007, DNA repair.

[8]  S. West,et al.  Actions of Aprataxin in Multiple DNA Repair Pathways* , 2007, Journal of Biological Chemistry.

[9]  K. Caldecott,et al.  APLF (C2orf13) Is a Novel Human Protein Involved in the Cellular Response to Chromosomal DNA Strand Breaks , 2007, Molecular and Cellular Biology.

[10]  C. Mothersill,et al.  A novel form of ataxia oculomotor apraxia characterized by oxidative stress and apoptosis resistance , 2007, Cell Death and Differentiation.

[11]  Y. Itoyama,et al.  DNA single‐strand break repair is impaired in aprataxin‐related ataxia , 2007, Annals of neurology.

[12]  K. Kohn,et al.  Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes. , 2006, DNA repair.

[13]  S. West,et al.  The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates , 2006, Nature.

[14]  P. Jeggo,et al.  Microcephalin: A Causal Link Between Impaired Damage Response Signalling and Microcephaly , 2006, Cell cycle.

[15]  Y. Pommier.  Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.

[16]  E. Petermann,et al.  Evidence That the ATR/Chk1 Pathway Maintains Normal Replication Fork Progression during Unperturbed S Phase , 2006, Cell cycle.

[17]  David J. Chen,et al.  Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. , 2006, DNA repair.

[18]  I. Glass,et al.  Senataxin, the yeast Sen1p orthologue: Characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease , 2006, Neurobiology of Disease.

[19]  J. Harris,et al.  Aprataxin Forms a Discrete Branch in the HIT (Histidine Triad) Superfamily of Proteins with Both DNA/RNA Binding and Nucleotide Hydrolase Activities* , 2006, Journal of Biological Chemistry.

[20]  G. C. Ferreira,et al.  Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. , 2006, Human molecular genetics.

[21]  A. Fischer,et al.  Cernunnos, a Novel Nonhomologous End-Joining Factor, Is Mutated in Human Immunodeficiency with Microcephaly , 2006, Cell.

[22]  J. Champoux,et al.  SCAN1 mutant Tdp1 accumulates the enzyme–DNA intermediate and causes camptothecin hypersensitivity , 2005, The EMBO journal.

[23]  C. Brenner,et al.  Disease-associated Mutations Inactivate AMP-Lysine Hydrolase Activity of Aprataxin*♦ , 2005, Journal of Biological Chemistry.

[24]  J. Lupski,et al.  Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1 , 2005, Nature.

[25]  Gemma K. Alderton,et al.  Nbs1 is required for ATR‐dependent phosphorylation events , 2005, The EMBO journal.

[26]  P. Mosesso,et al.  The novel human gene aprataxin is directly involved in DNA single-strand-break repair , 2005, Cellular and Molecular Life Sciences CMLS.

[27]  S. Tsuji,et al.  The FHA domain of aprataxin interacts with the C-terminal region of XRCC1. , 2004, Biochemical and biophysical research communications.

[28]  C. Brenner,et al.  The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4. , 2004, DNA repair.

[29]  M. Nussenzweig,et al.  ATM Is Required for Efficient Recombination between Immunoglobulin Switch Regions , 2004, The Journal of experimental medicine.

[30]  B. Chen,et al.  A New XRCC1-Containing Complex and Its Role in Cellular Survival of Methyl Methanesulfonate Treatment , 2004, Molecular and Cellular Biology.

[31]  D. Durocher,et al.  Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV , 2004, The EMBO journal.

[32]  Y. Furiya,et al.  Loss of function mechanism in aprataxin-related early-onset ataxia. , 2004, Biochemical and biophysical research communications.

[33]  C. Barlow,et al.  Failed Clearance of Aneuploid Embryonic Neural Progenitor Cells Leads to Excess Aneuploidy in the Atm-Deficient But Not the Trp53-Deficient Adult Cerebral Cortex , 2004, The Journal of Neuroscience.

[34]  D. Lane,et al.  Transcription — guarding the genome by sensing DNA damage , 2004, Nature Reviews Cancer.

[35]  P. Mckinnon.  ATM and ataxia telangiectasia , 2004, EMBO reports.

[36]  Osamu Onodera,et al.  Aprataxin, a novel protein that protects against genotoxic stress. , 2004, Human molecular genetics.

[37]  A. Burgin,et al.  Analysis of human tyrosyl-DNA phosphodiesterase I catalytic residues. , 2004, Journal of molecular biology.

[38]  D. Chan,et al.  The Protein Kinase CK2 Facilitates Repair of Chromosomal DNA Single-Strand Breaks , 2004, Cell.

[39]  A. Venkitaraman.  Tracing the network connecting brca and fanconi anaemia proteins , 2004, Nature Reviews Cancer.

[40]  J. Schulz,et al.  Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2 , 2004, Nature Genetics.

[41]  S. Tsuji,et al.  Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein , 2004, Annals of Neurology.

[42]  H. Dulce,et al.  Studies on the regulation of RNA synthesis in neuronal and glial nuclei isolated from rat brain , 1978, Experimental Brain Research.

[43]  S. Rivaud-Pechoux,et al.  Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies. , 2003, Brain : a journal of neurology.

[44]  A. Lehmann.  DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. , 2003, Biochimie.

[45]  K. Caldecott.  XRCC1 and DNA strand break repair. , 2003, DNA repair.

[46]  Stephen C. West,et al.  Molecular views of recombination proteins and their control , 2003, Nature Reviews Molecular Cell Biology.

[47]  Robert B. Wilson.  Frataxin and frataxin deficiency in Friedreich's ataxia , 2003, Journal of the Neurological Sciences.

[48]  K. Caldecott.  DNA Single-Strand Break Repair and Spinocerebellar Ataxia , 2003, Cell.

[49]  J. Champoux,et al.  Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. , 2002, Journal of molecular biology.

[50]  J. Lupski,et al.  Mutation of TDP1, encoding a topoisomerase I–dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy , 2002, Nature Genetics.

[51]  Y. Pommier,et al.  8-Oxoguanine rearranges the active site of human topoisomerase I , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Charles Brenner,et al.  Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. , 2002, Biochemistry.

[53]  S. West,et al.  Involvement of human polynucleotide kinase in double‐strand break repair by non‐homologous end joining , 2002, The EMBO journal.

[54]  L. D. Barnes,et al.  Adenosine Monophosphoramidase Activity of Hint and Hnt1 Supports Function of Kin28, Ccl1, and Tfb3* 210 , 2002, The Journal of Biological Chemistry.

[55]  Y. Pommier,et al.  Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase. , 2002, Nucleic acids research.

[56]  Daniel Durocher,et al.  The FHA domain , 2002, FEBS letters.

[57]  J. Champoux,et al.  The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. , 2002, Structure.

[58]  A. Barzilai,et al.  ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. , 2002, DNA repair.

[59]  P. Jeggo,et al.  DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. , 2001, Molecular cell.

[60]  T. Gibson,et al.  The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin , 2001, Nature Genetics.

[61]  S. Sugano,et al.  Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene , 2001, Nature Genetics.

[62]  J. Champoux,et al.  The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Barzilai,et al.  Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. , 2001, Cancer research.

[64]  M. Weinfeld,et al.  XRCC1 Stimulates Human Polynucleotide Kinase Activity at Damaged DNA Termini and Accelerates DNA Single-Strand Break Repair , 2001, Cell.

[65]  T. Lindahl,et al.  Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm. , 2000, Genes & development.

[66]  Y. Pommier,et al.  Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff , 2000, Molecular and Cellular Biology.

[67]  J. Pouliot,et al.  Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. , 1999, Science.

[68]  J. Sgouros,et al.  Molecular Characterization of a Human DNA Kinase* , 1999, The Journal of Biological Chemistry.

[69]  S. Scherer,et al.  Molecular Cloning of the Human Gene, PNKP, Encoding a Polynucleotide Kinase 3′-Phosphatase and Evidence for Its Role in Repair of DNA Strand Breaks Caused by Oxidative Damage* , 1999, The Journal of Biological Chemistry.

[70]  J. Morrow,et al.  Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  D. Barnes,et al.  Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice , 1998, Current Biology.

[72]  F. Alt,et al.  A Critical Role for DNA End-Joining Proteins in Both Lymphogenesis and Neurogenesis , 1998, Cell.

[73]  J. Morgan,et al.  Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. , 1998, Science.

[74]  Y. Pommier,et al.  Trapping of Mammalian Topoisomerase I and Recombinations Induced by Damaged DNA Containing Nicks or Gaps , 1997, The Journal of Biological Chemistry.

[75]  C. Lima,et al.  Structure-based analysis of catalysis and substrate definition in the HIT protein family. , 1997, Science.

[76]  G. Eichele,et al.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.

[77]  K. Kohn,et al.  Effects of Uracil Incorporation, DNA Mismatches, and Abasic Sites on Cleavage and Religation Activities of Mammalian Topoisomerase I* , 1997, The Journal of Biological Chemistry.

[78]  Y. Shiloh,et al.  Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. , 1997, Annual review of genetics.

[79]  P. Hasty,et al.  A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53 , 1996, Molecular and cellular biology.

[80]  A. Burgin,et al.  A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  D. Baltimore,et al.  Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. , 1996, Genes & development.

[82]  H. M. Geller,et al.  Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity , 1996, The Journal of cell biology.

[83]  F. Andermann,et al.  Ataxia—ocular motor aprilaxia: A syndrome mimicking ataxia‐telangiectasia , 1988 .

[84]  M. Seiji,et al.  Defective DNA repair replication in xeroderma pigmentosum fibroblasts and DNA repair of somatic cell hybrids after UV irradiation. , 1975, The Tohoku journal of experimental medicine.

[85]  J. Cleaver.  Defective Repair Replication of DNA in Xeroderma Pigmentosum , 1968, Nature.